ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience.
Jan-Willem BalderMariusz K SzymanskiLinda W van LaakePim van der HarstChristiaan L MeuweseFaiz Z RamjankhanManon G van der MeerJeannine A J M HermensMichiel VoskuilEric E C de WaalDirk W DonkerMarish I F J OerlemansAdriaan O KraaijeveldPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2024)
ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.